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A B S T R A C T
Background
Intrauterine insemination (IUI) is a common treatment for couples with subfertility that does not involve the fallopian tubes. It is
used to bring the sperm close to the released oocyte. Another method of introducing sperm is fallopian tube sperm perfusion (FSP).
Fallopian tube sperm perfusion ensures the presence of higher sperm densities in the fallopian tubes at the time of ovulation than does
standard IUI. These treatments are often used in combination with ovarian hyperstimulation.
Objectives
To compare intrauterine insemination versus fallopian tube sperm perfusion in the treatment of non-tubal subfertility, for live birth
and pregnancy outcomes.
Search methods
We searched the Menstrual Disorders and Subfertility Group Trials Register, MEDLINE, CINAHL and EMBASE from inception to
September 2013. We also searched study reference lists and trial registers.
Selection criteria
Randomised controlled trials (RCTs) comparing IUI with FSP in couples with non-tubal subfertility were included.
Data collection and analysis
Two review authors independently selected studies for inclusion, assessed study quality and extracted the data. If studies were sufficiently
similar, data were combined using a fixed-effect model to calculate pooled odds ratios (ORs) and 95% confidence intervals (CIs). A
random-effects model was used if substantial statistical heterogeneity was detected. Studies that included participants with unexplained
or mixed (non-tubal) subfertility were analysed separately from studies restricted to participants with mild or moderate male factor
subfertility. The overall quality of evidence for the main outcomes was summarised using Grading of Recommendations Assessment,
Development and Evaluation (GRADE) criteria.
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Main results
The review included 16 RCTs. Fourteen RCTs (1745 women) were included in the meta-analysis. Only three studies reported live
birth per couple. No evidence of a statistically significant difference was noted between IUI and FSP in live birth (OR 0.94, 95% CI
0.59 to 1.49, three RCTs, 633 women, I2 = 0%, low-quality evidence) or clinical pregnancy (OR 0.75, 95% CI 0.49 to 1.12, 14 RCTs,
1745 women, I2 = 52%, low-quality evidence). These findings suggest that for a couple with a 13% chance of live birth using FSP, the
chance when using IUI will be between 8% and 19%; and that for a couple with a 19% chance of pregnancy using FSP, the chance
of pregnancy when using IUI will be between 10% and 20%. Nor was evidence found of a statistically significant difference between
IUI and FSP in per-pregnancy of multiple pregnancy (OR 0.96, 95% CI 0.44 to 2.07, eight RCTs, 197 women, I2 = 0%, low-quality
evidence), miscarriage (OR 1.23, 95% CI 0.60 to 2.53, seven RCTs, 199 women, I2 = 0%, low-quality evidence) or ectopic pregnancy
(OR 1.71, 95% CI 0.42 to 6.88, four RCTs, 111 women, I2 = 0%, very low quality evidence). Substantial heterogeneity was noted for
the outcome of clinical pregnancy (I2 = 54%), for which no clear explanation was provided.
Authors’ conclusions
Currently no clear evidence suggests any difference between IUI and FSP with respect to their effectiveness and safety for treating
couples with non-tubal subfertility. However, a high level of uncertainty is evident in the findings, and additional research may be
useful.
P L A I N L A N G U A G E S U M M A R Y
Intrauterine insemination versus fallopian tube sperm perfusion for non-tubal infertility
Review question: This review compared intrauterine insemination versus fallopian tube sperm perfusion in the treatment of non-tubal
subfertility, for live birth and pregnancy outcomes.
Background: Intrauterine insemination (IUI) is an assisted reproduction procedure that places sperm directly into the uterus. Fallopian
tube sperm perfusion (FSP) is a similar procedure that places sperm into the woman’s fallopian tube, closer to the eggs than IUI. Both
techniques aim to improve the chance of conception.
Study characteristics: The review included 16 randomised controlled trials (more than 1800 women) that compared these procedures
for treating couples with non-tubal subfertility. Only three trials reported live birth. The evidence is current to September 2013. No
trial reported its funding source, but one reported no conflict of interest, and one stated that it had received no commercial funding.
Key results:No clear evidence suggests any difference between IUI and FSPwith respect to their effectiveness and safety in the treatment
of couples with non-tubal subfertility. However, a high level of uncertainty due to lack of data is evident in the findings.
Quality of the evidence: The overall quality of the evidence was rated as low for most outcomes, largely because of the small quantity
of available data.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
IUI compared with FSP for non- tubal infertility
Patient or population: women with non-tubal infert ility
Settings: subfert ility clinic
Intervention: intrauterine inseminat ion
Comparison: f allopian tube sperm perfusion
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* The basis for the assumed risk (the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is based on
the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).










































































































GRADE Working Group grades of evidence.
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1One of the three studies did not describe method of allocat ion concealment and 19% of women in this study had mild tubal
damage.
2Imprecision: Conf idence intervals cross the line of no ef fect and do not exclude an appreciable benef it or harm.
3Most studies failed to provide adequate details of methods of sequence generat ion and allocat ion concealment.












































































































B A C K G R O U N D
Description of the condition
Intrauterine insemination (IUI) is commonly offered to couples
with types of subfertility not involving the fallopian tubes. In-
trauterine insemination gained its popularity because it is a simple,
non-invasive, cost-effective technique (Hughes 1997). It is usually
combined with controlled ovarian hyperstimulation (COH).
Studies on the dynamics of sperm transport have found a pro-
gressive decline in the number of spermatozoa along the length of
the female reproductive tract. In normal fallopian tubes, a maxi-
mum of only 200 spermatozoa are present in the ampulla (Mamas
1996). Ripps 1994 showed that the number of spermatozoa in the
pouch of Douglas was very low after IUI. However, the number
of spermatozoa could be significantly increased with utero-tubal
flushes. On the other hand, some authors state that no correla-
tion exists between the number of spermatozoa inseminated and
subsequent pregnancy if at least one to five million spermatozoa
are inseminated (Dodson 1991; van Weert 2004). With consider-
ation of these observations, another simple non-invasive method
was introduced, called fallopian tube sperm perfusion.
Traditional parameters for assessing the quality of human semen
are the concentration, motility and morphology of sperm in the
ejaculate. Reference values are based on observations in popula-
tions of healthy men, and absolute minimal values for each se-
men parameter are unknown (Lewis 2007). Since 1990, theWorld
Health Organization (WHO) has published reference values with
cut-off points indicative of male subfertility. The 1997 WHO
criteria for male subfertility required at least one of the follow-
ing: sperm concentration (sperm count) less than 20 million per
milliliter, total motility less than 50% or normal morphology
less than 50% (WHO 1987). Criteria have changed over time,
with several revisions to these criteria, including changes in 1992,
which reduced the cut-off for sperm morphology from 50% to
30% (WHO 1992). The 2010 WHO criteria include thresholds
for sperm concentration of less than 15 million per milliliter, to-
tal motility less than 50% and normal morphology less than 4%
(WHO 2010).
Description of the intervention
Semen (from the partner or the donor) is prepared to remove de-
bris and to maximise the concentration of normal motile sperma-
tozoa. Common methods of sperm preparation are the ’swim-up
technique’, whereby motile spermatozoa swim up into a culture
medium, and the use of density gradients, which through centrifu-
gation separate spermatozoa according to their density (Boomsma
2007).
Interuterine insemination involves placement of about 0.5 mL of
inseminate into the uterine cavity, using a sterile, flexible catheter.
Fallopian tube sperm perfusion (FSP) is based on a pressure injec-
tion of 4 mL of sperm suspension while efforts are made to seal
the cervix to prevent semen reflux. This ensures sperm flushing of
the fallopian tubes and overflow of the inseminate into the pouch
of Douglas (Fanchin 1995).
How the intervention might work
FSP was developed to promote higher sperm densities in the fal-
lopian tubes at the time of ovulation than are provided with stan-
dard IUI.
However, a possible disadvantage of FSP is the large volume of
inseminate, which may flush the ova out of the tubes or induce
abnormalmyosalpingeal contractions, resulting in expulsion of the
ova from the tube and subsequent failure of fertilisation (Nuojua-
Huttunen 1997).
Why it is important to do this review
Numerous published randomised controlled trials (RCTs) have
compared the efficacy of FSP with that of standard IUI, and vari-
able findings have been reported. Some of these studies did not
have enough power to detect statistically significant differences;
therefore it seemed appropriate to consider pooling the results.
The aim of this review was to determine whether outcomes in
improving the probability of conception differ between FSP and
IUI. As one of the basic requirements for IUI, and subsequently
FSP, is the presence of patent tubes, we investigated the efficacy of
FSP and IUI in the treatment of non-tubal subfertility.
O B J E C T I V E S
To compare intrauterine insemination versus fallopian tube sperm
perfusion in the treatment of non-tubal subfertility, for live birth
and pregnancy outcomes.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Published and unpublished RCTs were eligible for inclusion. We
excluded non-randomised studies (e.g. studies with evidence of
inadequate sequence generation such as alternate days, participant
numbers), as they are associated with a high risk of bias.
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Cross-over trials were included, but we planned that only data
from the first phase would be included in meta-analyses, as the
cross-over design is not valid in this context.
Types of participants
Couples with non-tubal subfertility, including:
• couples with unexplained subfertility, defined as failure to
conceive after trying for at least one year, with no abnormality
found at a routine fertility checkup, or with other non-tubal
causes of subfertility, such as mild endometriosis;
• couples with mild to moderate male subfertility, defined as
semen quality not meeting the criteria for normality as defined
by the WHO in 1987. For the first full review and the first
update of the review, we used the 1987 definition of sperm
normality (sperm concentration < 20 × 106/mL, or total motility
< 50%, or normal morphology < 50%) to enable inclusion of
studies performed before 1992, as well as more recent studies. In
2010 the WHO changed the criteria for concentration to < 15 ×
106/mL; and
• couples with other non-tubal causes of subfertility (e.g.
mild endometriosis).
Types of interventions
Trials comparing intrauterine insemination versus fallopian tube
sperm perfusion were eligible for inclusion.
Types of outcome measures
Trials reporting at least one of the following outcomes were eligible
for inclusion.
Primary outcome
• Live birth per couple.
Secondary outcomes
• Clinical pregnancy per couple (defined as evidence of a
gestational sac, confirmed by ultrasound examination).
• Multiple pregnancy per couple.
• Miscarriage per couple.
• Ectopic pregnancy per couple.
Search methods for identification of studies
See Appendix 1; Appendix 2; Appendix 3; and Appendix 4 for
search strategies.
We searched for all published and unpublished RCTs of FSP ver-
sus IUI, with no language restriction and in consultation with
the Menstrual Disorders and Subfertility Group (MDSG) Trials
Search Co-ordinator.
Electronic searches
We searched the following databases from inception to September
2013.
• Menstrual Disorders and Subfertility Group Trials Register.
This register includes handsearching of all abstracts of meetings
of the American Society for Reproductive Medicine and the
European Society for Human Reproduction and Embryology
since 1987.
• MEDLINE.




• Trial registers for ongoing and registered trials (http://
clinicaltrials.gov/ct2/home, http://www.who.int/trialsearch/
Default.aspx).
• Conference abstracts and citations in the ISI Web of
Knowledge (http://wokinfo.com/)
• OpenGrey for unpublished literature from Europe (http://
www.opengrey.eu/)
Searching other resources
• We handsearched the reference lists of articles retrieved by
the search.
• We contacted experts in the field.
Data collection and analysis
Selection of studies
An initial screen of titles and abstracts retrieved by the search was
conducted by one review author (AEPC), and the full texts of
all potentially eligible studies were retrieved. Four review authors
(AEPC andMJH or CF or JM) independently selected the trials to
be included according to the above-mentioned criteria. Disagree-
ments were resolved through arbitration by a third review author
(BJC). We corresponded with study investigators as required to
clarify study eligibility.
Data extraction and management
Two review authors independently extracted data from eligible
studies (AEPC and MJH; for the update CF and JM). Disagree-
ments were resolved by discussion or by a third review author.
Data extracted included study characteristics and outcome data
(see Appendix 5). When studies had multiple publications, the
main trial report was used as the reference, and additional details
were derived from secondary papers. When important informa-
tion was missing from the original publications, attempts were
made to contact the primary investigators. Any additional infor-
mation received was incorporated into this review.
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Assessment of risk of bias in included studies
Two review authors independently assessed the included studies
for risk of bias using the Cochrane ’Risk of bias’ assessment tool
(www.cochrane-handbook.org) to assess allocation (random se-
quence generation and allocation concealment); blinding of par-
ticipants, personnel and/or outcome assessors; completeness of
outcome data; selective reporting; and other potential sources of
bias. Disagreements were resolved by discussion or by a third re-
view author. We described all judgements fully and presented the
conclusions in ’Risk of bias’ tables.
Measures of treatment effect
All outcomes were dichotomous. We used the numbers of events
in the control and intervention groups of each study to calculate
Mantel-Haenszel odds ratios (ORs) with 95%confidence intervals
(CIs). When data to calculate ORs were not available, we planned
to utilise the most detailed numerical data available that might
facilitate similar analyses of included studies (e.g. test statistics, P
values).
Unit of analysis issues
The primary analysis was performed per woman randomly as-
signed for all outcomes.
We planned that data that did not allow valid analysis (e.g. “per
cycle” data) would be briefly summarised in an additional table
and would not be meta-analysed.
Multiple live births (e.g. twins, triplets) were counted as one live
birth.
We planned to include only first-phase data from any cross-over
trials.
Dealing with missing data
Data were analysed on an intention-to-treat basis as far as possible,
and attempts were made to obtain missing data from the original
trialists. When these data were unobtainable, imputation of indi-
vidual values was undertaken for the primary outcome only: Live
births were assumed not to have occurred in participants without
a reported outcome. For other outcomes, only the available data
were analysed.
Assessment of heterogeneity
We consideredwhether clinical andmethodological characteristics
of the included studies were sufficiently similar for meta-analysis
to provide a clinically meaningful summary. We assessed statistical
heterogeneity by themeasure of the I2 statistic. An I2 measurement
greater than 50% was taken to indicate substantial heterogeneity
(Higgins 2011). A random-effects model was used if heterogeneity
was substantial.
Assessment of reporting biases
In view of the difficulty of detecting and correcting for publica-
tion bias and other reporting biases, the review authors aimed to
minimise the potential impact of such biases by ensuring a com-
prehensive search for eligible studies and by being alert for dupli-
cation of data. If ten or more studies were included in an analysis,
we planned to use a funnel plot to explore the possibility of small-
study effects (i.e. the tendency for estimates of the intervention
effect to be more beneficial in smaller studies).
Data synthesis
If the studies were sufficiently similar, we combined them using a
fixed-effect model to compare IUI versus FSP. An increase in the
odds of a particular outcome, which might be beneficial (e.g. live
birth) or detrimental (e.g. adverse effects), is displayed graphically
in the meta-analyses to the right of the centre-line, and a decrease
in the odds of a particular outcome is displayed to the left of the
centre-line.
Subgroup analysis and investigation of heterogeneity
We examined the effects of IUI versus FSP in the following sub-
groups, for the outcomes of live birth and clinical pregnancy.
• Participants with unexplained subfertility.
• Participants with mild or moderate male factor subfertility.
If we detected substantial statistical heterogeneity (I2 measurement
greater than 50%), we planned to explore possible explanations
in sensitivity analyses based on other clinical or methodological
differences between the studies.
Sensitivity analysis
We conducted sensitivity analyses for the outcome of clinical preg-
nancy to determine whether the conclusions were robust to arbi-
trary decisions made regarding study eligibility and analysis. These
analyses included consideration of whether the review conclusions
would have differed if:
• eligibility were restricted to studies with lower risk of bias
(defined as studies with a low risk of bias related to
randomisation and allocation concealment); or
• a random effects model had been adopted.
We also conducted sensitivity analyses for the outcomes of mul-
tiple pregnancy, miscarriage and ectopic pregnancy to determine
whether our conclusions would have differed if the unit of analysis
had been pregnancy rather than couple.
Overall quality of the body of evidence: ’Summary of
findings’ table
A ’Summary of findings’ table was generated using GRADEPRO
software. This table evaluated the overall quality of the body of
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evidence for the main review outcomes, using GRADE criteria
(study limitations (i.e. risk of bias), consistency of effect, impre-
cision, indirectness and publication bias). Judgements about evi-
dence quality (high, moderate or low) were incorporated into our
interpretation of findings.
R E S U L T S
Description of studies
Results of the search
Eleven studies were included in the original review (published in
2004), and twelve in the 2009 update. Additional information
was received from the authors of the following included studies:
Biacchiardi 2004; Filer 1996a; Gregoriou 1995; Papier 1998, and
the following excluded studies: Maheshwari 1998; Prietl 1999.
For the 2013 update, three new studies were added (El-Khayat
2012; Farquhar 2013; Furuya 2010), two studies previously clas-
sified as “awaiting assessment” were included (Kamel 1999; Noci
2007) and two previously included studies (Trout 1999 and Trout
1999 extension study) were amalgamated under a single reference.
Therefore the review now includes 16 studies (Biacchiardi 2004;
El-Khayat 2012; El Sadek 1998; Fanchin 1995; Farquhar 2013;
Filer 1996; Furuya 2010; Gregoriou 1995; Kahn 1993; Kamel
1999;Ng2003;Noci 2007;Nuojua-Huttunen 1997; Papier 1998;
Ricci 2001; Trout 1999). In addition, one study is awaiting assess-
ment (Ricci 2008).
Study flow is shown in Figure 1.
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Figure 1. Study flow diagram.
Included studies
Design
The sample sizes of the 16 included studies ranged from 56 to
417 couples, where stated. One study of 106 cycles (Filer 1996)
did not clearly state how many women were included. The other
15 studies included a total of 1855 women. Thirteen studies used
a parallel-group design. The other three (Biacchiardi 2004; Filer
1996; Kamel 1999) used a cross-over design. Pre-cross-over data
were available for Filer 1996 and Kamel 1999. Most were single-
centre studies. Studies were conducted in tertiary institutions in
Argentina, Denmark, Egypt, Finland, France, Greece, Hongkong,
Italy ,Japan, New Zealand, Norway and the USA. None reported
their funding source, but one reported no conflict of interest (El-
Khayat 2012), and one stated that it had received no commercial
funding (Ng 2003).
Participants
The mean or median duration of subfertility among participants
in the included studies was about 3.5 years (range 2.0 to 4.4 years)
in most studies. Two studies included women with a longer mean
duration of subfertility (El Sadek 1998; Gregoriou 1995), and one
(Trout 1999) did not state the mean duration of subfertility. Mean
age of participants ranged from 29 to 36 years, where stated. In
one study (Ng 2003), 24% of women had secondary subfertility.
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The most common causes of subfertility in the included stud-
ies were unexplained infertility and male factor infertility. Other
diagnoses included mild endometriosis, ovarian dysfunction and
cervical factor. Two studies reported that although they excluded
women with obstructed tubes (El Sadek 1998) and/or severely
damaged tubes (Fanchin 1995), they included some with mild
tubal damage. In El Sadek 1998, 19% of women had light per-
itubal adhesions or slightly reduced tubal fimbriae and/or moder-
ate loss of gracility of the tubes. In Fanchin 1995, 37% of women
had partial tube damage.
Two studies were restricted to couples with mild or moderate male
factor infertility (El-Khayat 2012; Kamel 1999). In several other
studies, a proportion of couples had mild male factor subfertility
(when severity was reported): Ng 2003 (37%); Noci 2007 (19%);
Nuojua-Huttunen 1997 (9%); Trout 1999 (16%); and Papier
1998 (proportion not stated).
Most studies included hysterosalpingography or laparoscopy to
check tubal patency as part of the fertility investigative workup.
Interventions
1. Stimulation methods
Stimulation methods included the following:
• Clomiphene citrate (CC) alone or combined with human
menopausal gonadotrophin (hMG), followed by one dose of
human chorionic gonadotrophin (hCG): El Sadek 1998;
El-Khayat 2012; Kahn 1993; Nuojua-Huttunen 1997; Kamel
1999;
• Follicle-stimulating hormone (FSH) plus one dose of hCG:
Ricci 2001 (urinary FSH); Biacchiardi 2004 (recombinant FSH);
• hMG alone followed by one dose of hCG when the leading
follicle was > 18 mm in diameter: Gregoriou 1995; Ng 2003;
Papier 1998; and
• hMG or urinary FSH, plus one dose of hCG when leading
follicle was > 18 mm and 2 others were > 16 mm (Noci 2007).
Two studies used a variety of stimulation protocols. Farquhar 2013
used no stimulation for 10% of women and used CC, FSH or
letrozole for the remainder. Fanchin 1995 used hMG, FSH and/
or gonadotrophin-releasing hormone agonist (GnRHa).
Two studies (Filer 1996; Furuya 2010) did not mention the type
of stimulation used.
2. Semen preparation
When reported, studies used semen from the partner, except that
10% of cycles used donor sperm in Farquhar 2013. The volume of
semen perfused for the FSP procedure was 4.0mL in most studies.
For the IUI technique, the volume of semen used varied between
0.2 mL and 1.0 mL.
Semen preparation methods included the following.
• Density gradient centrifugation techniques: Fanchin 1995;
Farquhar 2013; Filer 1996; Gregoriou 1995; Ng 2003; Noci
2007; Nuojua-Huttunen 1997; Papier 1998; Trout 1999.
• Swim-up techniques: Biacchiardi 2004; El Sadek 1998;
El-Khayat 2012; Kahn 1993; Kamel 1999; Ricci 2001.
One study (Furuya 2010) did not report the methods used for
semen preparation.
3. Timing of intervention
Insemination or perfusionwas between 34 and 42 hours after hCG
in all trials. All studies performed a single insemination for both
groups.
4. Catheters
Catheters used for IUI were as follows.
• Frydman: El Sadek 1998; Fanchin 1995; Kahn 1993;
Kamel 1999; Noci 2007; Papier 1998; Ricci 2001.
• Tomcat: Ng 2003.
• Tomcat or Wallace: Farquhar 2013.
• Kremer de la Fontaine: Biacchiardi 2004;
Nuojua-Huttunen 1997.
• Makler: Filer 1996; Gregoriou 1995.
• Conventional IUI canula: Trout 1999.
• Insulin syringe attached to an artificial insemination
catheter: El-Khayat 2012.
Catheters used for FSP were as follows.
• Frydman with Allis clamp: El Sadek 1998; Gregoriou 1995;
Kahn 1993; Kamel 1999.
• FAST system: Fanchin 1995; Ricci 2001.
• Foley catheter: Biacchiardi 2004; Nuojua-Huttunen 1997;
El-Khayat 2012.
• Intrauterine injector with balloon: Ng 2003.
• Makler cannula: Filer 1996; Papier 1998.
• ZUII catheter with balloon: Trout 1999.
• Hysterosalpingography (Cervix Adaptor) catheter: Noci
2007.
One study (Furuya 2010) did not describe the catheters used.
5. Number of cycles
The maximum number of cycles included in the studies varied as
follows.
• One cycle: Farquhar 2013; Nuojua-Huttunen 1997; Papier
1998.
• Three cycles: Furuya 2010; Gregoriou 1995; Kamel 1999;
Kahn 1993; Ng 2003; Noci 2007; Ricci 2001.
• Four cycles: Biacchiardi 2004.
• Six cycles: Filer 1996.
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Other studies (El-Khayat 2012; El Sadek 1998; Fanchin 1995;
Trout 1999) did not report a maximum number of cycles per
couple.
Outcomes
Primary outcome: live birth
Only three studies reported live birth (El Sadek 1998; El-Khayat
2012; Farquhar 2013).
Secondary outcomes
• Clinical pregnancy was reported by all studies. ’Per couple’
data were reported by all but two studies (Fanchin 1995; Filer
1996), which reported only per-cycle data.
• Multiple pregnancy was reported by eight studies: El Sadek
1998; El-Khayat 2012; Fanchin 1995; Farquhar 2013; Kahn
1993; Ng 2003; Nuojua-Huttunen 1997; Ricci 2001.
• Miscarriage was reported by seven studies: El Sadek 1998;
El-Khayat 2012; Farquhar 2013; Kahn 1993; Ng 2003;
Nuojua-Huttunen 1997; Ricci 2001.
• Ectopic pregnancy was reported by four studies: El-Khayat
2012; Farquhar 2013; Kahn 1993; Ricci 2001.
For full details of the included studies, see Characteristics of
included studies.
Excluded studies
Twenty-two studies were excluded because they did not per-
form the comparison of interest or were not randomised con-
trolled trials: Allahbadia 1998; Arroyo Vieyra 1995; Ciftci 1998;
Desai 1998; Dodson 1998; Elhelw 2000; Fanchin 1996; Fanchin
1997; Kahn 1992; Kahn 1992a; Kahn 1993a; Karande 1995;
Levitas 1999; Li 1993; Maheshwari 1998; Mamas 1996; Mamas
2006; Posada 2005; Prietl 1999; Soliman 2005; Soliman 1999;
Shekhawat 2012.
See Characteristics of excluded studies for details.
Risk of bias in included studies
See Figure 2 and Figure 3.
Figure 2. Methodological quality graph: review authors’ judgements about all methodological quality items
presented as percentages across all included studies.
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Figure 3. Methodological quality summary: review authors’ judgements about all methodological quality
items for each included study.
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Allocation
Sequence generation
Thirteen studies reported adequate methods of sequence genera-
tion and were rated as at low risk of bias in this domain. The other
three studies did not clearly describe their methods and were rated
as at unclear risk of bias.
Allocation concealment
Seven studies reported adequate methods of allocation conceal-
ment and were rated as at low risk of bias in this domain. The
other nine studies did not clearly describe their methods and were
rated as at unclear risk of bias.
Blinding
Blinding was not reported in any of the studies. However, all
studies were rated as at unclear risk of performance or detection
bias, as it was uncertain whether blinding would influence the
outcomes reported in this review.
Incomplete outcome data
Fourteen studies reported outcomes for all or nearly all randomly
assigned participants and were rated as at low risk of attrition bias.
In one study (Papier 1998),16% of women failed to receive the
intervention, and another study (Fanchin 1995) did not report
per-couple data: These two studies were rated as at unclear risk of
attrition bias.
Selective reporting
Only three studies reported live birth (El Sadek 1998; El-Khayat
2012; Farquhar 2013). These studies were rated as at low risk of
selection bias. The other studies failed to report live birth and in
some cases also failed to report adverse events. These studies were
rated as at unclear risk of selective reporting.
Other potential sources of bias
No other potential source of bias was identified in nine studies;
these were rated as at low risk of bias. Limited information was
available for two studies, as they were unpublished or were pub-
lished only as abstracts (Furuya 2010; Kamel 1999). Two stud-
ies noted that the number of motile sperm inseminated differed
between the groups (Gregoriou 1995; Ng 2003), and one study
randomly assigned women but reported results per cycle (Fanchin
1995). Two studies included some women with mild tubal dam-
age (El Sadek 1998; Fanchin 1995). These six studies were rated
as at unclear risk of other bias. One study was rated as at high risk
of bias because it used a cross-over design, which is not valid for
studies reporting pregnancy outcomes, and no pre-cross-over data
were available.
Effects of interventions
See: Summary of findings for the main comparison IUI
compared with FSP for non-tubal infertility
Primary outcome: live birth per couple
Three studies reported this outcome. There was no evidence of a
statistically significant difference between IUI and FSP (OR 0.94,
95%CI 0.59 to 1.49, three RCTs, 633 women, I2 = 46%; Analysis
1.1; Figure 4).
Figure 4. Forest plot of comparison: 1 NEW Intrauterine insemination versus fallopian tube sperm
perfusion, outcome: 1.1 Live birth per couple.
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Secondary outcomes
1. Clinical pregnancy
Fourteen studies reported this outcome. There was substantial
heterogeneity (I2 = 52%), and so a random-effects model was used
with no evidence of a statistically significant difference between
IUI and FSP (OR 0.75, 95% CI 0.49 to 1.12, 14 RCTs, 1745
women, I2 = 52%; Analysis 1.2; Figure 5)
We conducted sensitivity analyses, restricting the analyses to stud-
ies using similar methods of stimulation, similar catheter types and
or similar methods of semen preparation (data not shown), but
this did not explain the heterogeneity.
Figure 5. Forest plot of comparison: 1 IUI vs FSP: unexplained or mixed (non-tubal) causes, outcome: 1.2
Clinical pregnancy per couple (unexplained and mixed causes).
One study of 74 couples (Fanchin 1995) reported only “per-cycle”
data and so was not included in the meta-analysis (Table 1). The
clinical pregnancy rate was significantly higher in the FSP group
in this study (20% vs 40%; P < 0.04).
2. Multiple pregnancy
Seven studies reported this outcome. No evidence was found of a
statistically significant difference between IUI and FSP (OR 0.62,
95% CI 0.29 to 1.32, seven RCTs, 908 women, I2 = 0%; Analysis
1.3).
Sensitivity analysis using pregnancy as the unit of analysis also
found no significant differences between groups (Analysis 1.3).
3. Miscarriage
Seven studies reported this outcome. No evidence was found of a
statistically significant difference between IUI and FSP (OR 1.07,
95% CI 0.56 to 2.05, seven RCTs, 884 women, I2 = 0%; Analysis
1.4).
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Sensitivity analysis using pregnancy as the unit of analysis also
found no significant differences between groups (Analysis 1.4).
4. Ectopic pregnancy
Four studies reported this outcome. No evidence was found of a
statistically significant difference between IUI and FSP (OR 0.88,
95% CI 0.24 to 3.19, four RCTs, 643 women, I2 = 0%; Analysis
1.5).
Sensitivity analysis using pregnancy as the unit of analysis also
found no significant differences between groups (Analysis 1.5).
Subgroup analyses
1. Live birth and clinical pregnancy in couples with
unexplained subfertility
No studies reported live birth in this subgroup.
Seven studies were restricted to couples with unexplained subfer-
tility or reported separate statistical data on this group. When data
were pooled, no evidence was found of a statistically significant
difference in clinical pregnancy between the IUI group and the
FSP group (OR 0.63, 95% CI 0.39 to 1.02, seven studies, 378
couples, I2 = 66%). Heterogeneity for this analysis was high, for
which there was no obvious explanation.
2. Live birth and clinical pregnancy in couples with mild or
moderate male factor subfertility
One study reported live birth in this subgroup. No evidence was
found of a statistically significant difference between groups in live
birth (OR 0.40, 95% CI 0.14 to 1.14, one study, n = 120).
Five studies were restricted to couples with male factor subfertility
or reported separate statistical data for this group. When data
were pooled, no evidence was found of a statistically significant
difference in clinical pregnancy between the IUI group and the
FSP group (OR 0.53, 95% CI 0.28 to 1.01, five studies, 303
couples, I2 = 0%).
Assessment of reporting bias
A funnel plot for the outcome of clinical pregnancy was not sug-
gestive of reporting bias (Figure 6).
Figure 6. Funnel plot of comparison: 1 IUI versus FSP, outcome: 1.2 Clinical pregnancy per couple.
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Sensitivity analyses
Restriction to higher-quality studies or use of risk ratio rather
than odds ratio did not substantially influence the overall findings
for clinical pregnancy. In a post hoc sensitivity analysis, exclusion
of the two studies in which some of the women had mild tubal
damage did not influence the main findings.
D I S C U S S I O N
Summary of main results
The aim of this review was to compare intrauterine insemination
and fallopian tube sperm perfusion in the treatment of non-tubal
subfertility, with respect to live birth, clinical pregnancy and ad-
verse effects. No good evidence suggested any difference between
IUI and FSP with respect to their effectiveness or safety in treating
non-tubal subfertility. Findings suggest that for a couple with a
13% chance of live birth using FSP, the chance when using IUI
will be between 8% and 19%; and that for a couple with a 19%
chance of pregnancy using FSP, the chance of pregnancy when
using IUI will be between 10% and 20%.
The evidence was of low quality. Moreover, the analyses of preg-
nancy rates appeared underpowered, with some suggestion of ben-
efit for FSP.
We concluded that currently no good evidence suggests any dif-
ference between IUI and FSP with respect to their safety and ef-
fectiveness in treating non-tubal subfertility.
Overall completeness and applicability of
evidence
A number of methodological considerations have to be considered
when interpreting the results as clinical heterogeneity was noted
in the included trials, as well as substantial statistical heterogeneity
for the outcome of clinical pregnancy.
Types of subfertility differed between and within the trials and
included unexplained subfertility, ovarian dysfunction, cervical
factor, light peritubal adhesions, mild endometriosis and mild to
moderate male factor subfertility.
Studies were similar with regard to mean participant age. Most
studies excluded women over 39 years of age. Most fertility re-
search centres have a maximum age of inclusion because of lower
success rates with older women, related to lower ovarian reserve
and oocyte quality in women over 40 years of age (Bukman 2000).
The duration of subfertility was at least one year in all of the stud-
ies (where reported) and was commonly longer than three years.
It is known that fertility treatment is less successful with longer
duration of subfertility.
The method of controlled ovarian hyperstimulation used varied
among the included studies. Previous meta-analyses (Cantineau
2007; Crosignani 1996; Hughes 1997) have concluded that go-
nadotrophins are more effective than clomiphene citrate in the
treatment of subfertile couples in IUI programmes. However, the
largest included study (Dankert 2007) inCantineau 2007 reported
no statistically significant difference in effectiveness between CC
and gonadotrophins. More aggressive ovarian stimulation is likely
to increase pregnancy as well as multiple pregnancy and ovarian
hyperstimulation syndrome (OHSS); this should be taken into
account when study results are compared. In the current review,
randomisation was done on the day of insemination after ovarian
stimulation, so the ovarian stimulation method was unlikely to
influence FSP and IUI outcomes.
Differing methods of sperm preparation were used and included
both swim-up and gradient techniques. Use of a gradient might
yield a higher recovery rate (Cohlen 1998), although a Cochrane
review on recovery rates after different semen analysis techniques
concluded that no semen preparation technique is superior to
another (Boomsma 2007).
Differing catheters were also used. Different types of IUI catheters
have been compared in a Cochrane review (van der Poel 2010),
but no specific conclusion could bemade regarding the superiority
of one catheter class over another.
Quality of the evidence
Themost commonproblems involving the quality of studies in this
review were failure to report live birth as an outcome and failure
to describe an acceptable method of allocation concealment. Most
studies described acceptable methods of sequence generation and
were at low risk of attrition bias or other sources of bias. One
study reported only per-cycle data. All studies were apparently
unblinded, but this was considered unlikely to cause bias.
As noted above, some analyses appeared underpowered.
Publication bias appeared unlikely, as a funnel graph for the out-
come of clinical pregnancy was symmetrical (see Figure 6).
Using GRADE methods, the overall quality of the evidence was
rated as low for all outcomes apart from ectopic pregnancy, for
which it was rated as very low. This was largely a result of the small
quantity of data available, which resulted in wide confidence inter-
vals that were compatible both with no effect and with appreciable
benefit or harm. In addition, most studies did not describe their
methods in adequate detail. For the outcome of clinical pregnancy,
substantial heterogeneity was noted, which was not adequately ex-
plained by clinical differences between the studies. See Summary
of findings for the main comparison.
Potential biases in the review process
We are unaware of any potential biases in the review process.
Agreements and disagreements with other
studies or reviews
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No other reviews comparing fallopian tube sperm perfusion with
intrauterine insemination are known to the review authors.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This review of 16 RCTs found no good evidence suggesting any
difference between IUI and FSP with respect to safety and effec-
tiveness in treating non-tubal subfertility. Findings suggest that
for a couple with a 13% chance of live birth using FSP, the chance
when using IUI will be between 8% and 19%; and that for a cou-
ple with a 19% chance of pregnancy using FSP, the chance when
using IUI will be between 10% and 20%. Familiarity with one
procedure may be more important than the technique itself.
Implications for research
Further RCTs in this area may be justified, as the current evidence
appears underpowered. If such RCTs are undertaken, they should
report live birth as an outcome, as well as clinical pregnancy and
adverse effects, and should stratify participants by indication for
treatment.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Biacchiardi 2004
Methods Randomisation: blocked computer-generated sequence of numbers
Trial design: cross-over
Concealment of allocation: adequate
Participants Participants: 56 women; 127 cycles
Age of women: 33.2 ± 4.3 years for the total group
Duration of subfertility: total group 2.4 ± 1.3 years
Type of subfertility: unexplained subfertility (not further defined-mean duration of in-
fertility 2.4 years)
Interventions Stimulation method: rFSH 75 IU from CD 3
Intervention: IUI or FSP 35 to 37 hours after hCG, with husband’s semen
Semen preparation: swim-up
Catheter used: IUI: Kremer de la Fontaine
FSP: Foley catheter
Maximum number of cycles per couple: 4
Outcomes Clinical pregnancy per couple
Multiple pregnancy
Miscarriage
Notes Additional details received from authors. Pre-cross-over data available
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated sequence of numbers
blind to the operators
Allocation concealment (selection bias) Low risk Adequate
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Pre-cross-over data reported for all ran-
domised participants (n = 56)
Selective reporting (reporting bias) Unclear risk Live birth not reported. OHSS not re-
ported
Other bias Low risk No other potential source of bias noted
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El Sadek 1998
Methods Randomisation: block randomisation list
Trial design: parallel
Concealment of allocation: adequate
Participants Participants: 96 women; 100 cycles
Age of women: IUI 31.5 ± 5.3 years; FSP 32.0 ± 5.2 years
Duration of subfertility: IUI 8.6 ± 2.1 years; FSP 7.3 ± 1.9 years
Type of subfertility: unexplained subfertility, light peritubal adhesions*, PCO, cervical
hostility
*19% of participants with light peritubal adhesions or slightly reduced tubal fimbriae
and/or moderate loss of gracility of the tubes. Women with obstructed tubes excluded
Interventions Stimulation method: CC or CC + hMG + hCG
Intervention: IUI or FSP 34 to 36 hours after hCG, with husband’s semen
Semen preparation: swim-up
Catheter used: Frydman catheter (with Allis clamp for FSP)






Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Blocked randomization list”
Allocation concealment (selection bias) Unclear risk No details reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Data reported for all randomised partici-
pants (n = 96)
Selective reporting (reporting bias) Low risk Reported live birth and adverse events
22Intrauterine insemination versus fallopian tube sperm perfusion for non-tubal infertility (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
El-Khayat 2012
Methods Randomisation: computer-generated random numbers
Trial design: parallel
Concealment of allocation: adequate
Participants Participants: 120 women
Age of women: mean 29 years
Duration of subfertility: mean 3.4 to 3.6 years
Type of subfertility: mild to moderate male factor infertility, defined as sperm count less
than 15 × 106/mL, total motility less than 40% or normal forms less than 4%-perWHO
criteria. Patients with severe oligospermia (<5 × 106/mL) excluded
Interventions Stimulation method: CC + hMG
Intervention: IUI or FSP 34 to 36 hours after hCG, with partner’s semen
Semen preparation: double-wash and swim-up
Catheter used: insulin syringe attached to an artificial insemination catheter for IUI;
pediatric Foley catheter for FSP
Maximum number of cycles per couple: not stated
Outcomes Clinical pregnancy (positive β-hCG test confirmed by ultrasound)
Multiple pregnancy
Miscarriage
Notes Author sent data on allocation concealment and live birth by personal communication
4.4.13
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random numbers
Allocation concealment (selection bias) Low risk “Closed sealed consecutively numbered
opaque envelopes” (personal communica-
tion with author)
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Data reported for all randomised partici-
pants (n = 120)
Selective reporting (reporting bias) Low risk Reported live birth and adverse events
Other bias Low risk No other potential source of bias noted
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Fanchin 1995
Methods Randomisation: block randomisation list
Power analysis: not stated
Trial design: parallel
Concealment of allocation: not stated
Participants Participants: 74 women; 100 cycles
Age of women: IUI 31.8 ± 4.6 years; FSP 31.8 ± 3.7 years
Duration of subfertility: IUI 3.6 ± 1.2; FSP 3.4 ± 1.1 years
Type of subfertility: partial tube damage*, idiopathic, cervical, ovulatory
*37% of women with partial tube damage. Women with severe tubal damage or ob-
structed tubes excluded
Interventions Stimulationmethod: (1)CC+hMG; (2) hMGalone; (3) FSH, hMGandGnRH agonist
All followed by hCG
Intervention: IUI or FSP 36 hours after hCG with husband’s semen
Sperm preparation: Percoll gradient
Catheter used: Frydman catheter for IUI and FSP with FAST system





Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Blocked randomisation list
Allocation concealment (selection bias) Unclear risk No details reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding not reported
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Data reported for all cycles, but number of
women in each group not reported
Selective reporting (reporting bias) Unclear risk Not stated
Other bias Unclear risk Unit of analysis error-women randomised,
but data reported per cycle. 37% of women
had mild tubal damage
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Farquhar 2013
Methods Randomisation: block randomisation list
Trial design: parallel
Concealment of allocation: serial numbered opaque sealed envelopes
Pragmatic multicentred study design
Participants Participants: 417 women; one cycle each
Age of women: IUI 33.67 ± 4.87; FSP 34.23 ± 4.62 years
Duration of subfertility: (median) IUI 24 (IQR 9 to 42); FSP 24 (IQR 11 to 36) months
Type of subfertility: non-tubal infertility, 10% donor cycles
Interventions Stimulation method: CC or FSH or letrozole (10% were unstimulated)
Intervention: IUI or FSP 34 to 36 hours after hCG, with husband’s semen
IUI Catheter: Tomcat or Wallace catheter used for the IUI procedure. Inseminate pre-
pared using a density gradient (Puresperm), and spermatozoa re-suspended in 0.5 mL
of medium, as used in the recruiting centre. Catheter passed gently through the cervical
canal high up into the uterus, and specimen with a volume of 0.5 mL slowly injected
according to standard unit protocol
FSP catheter: atraumatic insemination catheter (Cook catheter J-CHSG-503000) used
for the FSP procedure
Sperm preparation: inseminate prepared using a density gradient (Puresperm), and sper-
matozoa re-suspended in 4 mL of human tubal fluid or equivalent medium, as used in
the recruiting centre. Catheter attached to a 5-mL syringe







Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “computer-generated randomisation se-
quence of random blocks of 3 different
sizes, chosen randomly (with equal proba-
bility of getting 6, 8 or 10 in each block)”
Allocation concealment (selection bias) Low risk “Allocation numbers were placed in indi-
vidual, sealed, opaque envelopes that were
numbered sequentially”
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No blinding
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Farquhar 2013 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk 6 withdrawals and 1 missing data
Selective reporting (reporting bias) Low risk No major protocol changes in outcomes
Other bias Low risk No other potential source of bias noted
Filer 1996
Methods Randomisation: computer-generated algorithm
Power analysis: not stated
Trial design: cross-over
Concealment of allocation: adequate
Participants Participants: 106 cycles
Age of women: < 40 years
Duration of subfertility: at least one year
Type of subfertility: unexplained
Interventions Stimulation method: not stated
Intervention: IUI or FSP 36 to 42 hours after hCG
Sperm preparation: Percoll gradient
Catheter used: Makler cannula for IUI and FSP
Maximum number of cycles per couple: 6
Outcomes Pregnancy
Notes Additional details received from authors
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated algorithm
Allocation concealment (selection bias) Low risk After additional information from the au-
thor
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No blinding reported
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Data reported per cycle only-number of
couples not reported
Selective reporting (reporting bias) Unclear risk Adverse events not reported
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Filer 1996 (Continued)
Other bias High risk No pre-cross-over data reported. Limited
information, as study available only as ab-
stract
Furuya 2010
Methods Randomisation: not stated
Power analysis: not stated
Trial design: parallel
Concealment of allocation: not stated
Participants Participants: 158 women, 322 cycles
Age of women: not stated
Duration of subfertility: not stated
Type of subfertility: non-tubal infertility
Interventions Stimulation method: not stated
Intervention: IUI or FSP
Sperm preparation: not stated
Catheter used: not stated
Maximum number of cycles per couple: 3
Outcomes Pregnancy
Notes
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk States “theywere randomised” ... no further
details
Allocation concealment (selection bias) Unclear risk No details reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No blinding reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Results reported for all randomised women
(n = 158)
Selective reporting (reporting bias) Unclear risk Live birth and adverse effects not reported.
Other bias Unclear risk Limited reporting-abstract available only
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Gregoriou 1995
Methods Randomisation: list of random numbers
Trial design: parallel
Concealment of allocation: adequate
Participants Participants: 60 women; 150 cycles
Age of women: IUI 30.4 ± 3.5 years; FSP 30.3 ± 3.6 years
Duration of subfertility: IUI 6.5 ± 2.1 years; FSP 6.3 ± 2.5 years
Type of subfertility: unexplained subfertility
Mean duration of unexplained infertility 6.5 years (range 2 to 12 years)
Interventions Stimulation method: hMG 75 IU from CD 3
Intervention: IUI or FSP 36 hours after hCG with husband’s semen
Sperm preparation: two-layer Percoll gradient
Catheter used: Makler device for IUI and Frydman catheter (with Allis clamp) for FSP
Maximum number of cycles per couple: 3
Outcomes Pregnancy
Notes Additional details received from authors
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk List of random numbers
Allocation concealment (selection bias) Low risk Adequate
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No blinding reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcomes reported for all women ran-
domised (n = 60)
Selective reporting (reporting bias) Unclear risk Live birth not reported, adverse effects not
reported
Other bias Unclear risk Number of motile sperm inseminated was
significantly higher in the FSP group
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Kahn 1993
Methods Randomisation method: not stated
Trial design: parallel
Concealment of allocation: sealed envelopes
Power analysis: not stated
Participants Participants: 60 women; 103 cycles
Age of women: IUI 31.8 ± 0.8 years; FSP 31.7 ± 0.6 years
Duration of subfertility: > 3 years
Type of subfertility: unexplained infertility
Minimum duration of unexplained infertility 3 years (range 3 to 6 years)
Interventions Stimulation method: CC + hMG + hCG
Intervention: IUI or FSP 34 to 37 hours after hCG with husband’s semen
Semen preparation: swim-up
Catheter used: Frydman catheter (with Allis clamp for FSP)
Maximum number of cycles per couple: 3





Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “The women were randomized for treat-
ment with IUI or FSP on the day of HCG
administration, by drawing a sealed enve-
lope”. No further details provided
Allocation concealment (selection bias) Unclear risk As above
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No blinding reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Results reported for 58/60 women ran-
domised (97%). Two women dropped out
in IUI group-reasons explained
Selective reporting (reporting bias) Unclear risk Live birth not reported
Other bias Low risk No other potential source of bias noted
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Kamel 1999
Methods Randomisation method: not stated
Trial design: cross-over
Concealment of allocation: not reported
Participants 120 couples, moderate male factor infertility (not further defined)
Interventions Stimulation method: CC 100 mg from day 3 to 8 when one follicle reached 18 mm
Intervention: IUI with 0.5 mL of the sample or FSP 4 mL injected intrauterine under
pressure after closure of the cervix with husband’s semen
Semen preparation: swim-up
Catheter used: Frydman catheter (with Allis clamp for FSP)
Maximum number of cycles per couple: 3 (on one treatment)
Outcomes Pregnancy for pre-cross-over and post-cross-over data
Notes Crossover: if no pregnancy occurred, method of insemination changed to that of the
other group 3 months later
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk States “random cross-over study”-no fur-
ther details
Allocation concealment (selection bias) Unclear risk No details reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No blinding reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Results reported for all women randomised
(n = 120)
Selective reporting (reporting bias) Unclear risk Live birth and adverse effects not reported
Other bias Unclear risk Limited reporting-abstract available only
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Ng 2003
Methods Randomisation method: computer-generated randomisation list
Trial design: parallel
Concealment of allocation: not stated
Follow-up: 3 cycles
Power analysis: yes
Intention-to-treat analysis: not performed
Participants Participants: 90 women; 204 cycles
(1) IUI 30 women, 68 cycles; (2) IUI 30 women, 76 cycles; and (3) FSP 30 women, 59
cycles
Age of women: (1) IUI 32.7 ± 2.4 years; (2) IUI 32.9 ± 2.7 years
Duration of subfertility: (1) IUI 4.4 ± 1.7; (2) IUI 4.2 ± 2.1 years
22/90 women had secondary infertility
Type of subfertility: male factor (37%), unexplained subfertility and endometriosis
Male subfertility not defined. All participants had > 10 million sperm in ejaculate during
workup
Interventions Stimulation method: 150 IU hMG fromCD3, dosage titrated later according to ovarian
response; 10.000 IU hCG (1) IUI 38 hours after hCG; (2) FSP 38 hours after hCG; (3)
IUI 18 and 38 hours after hCG with partner’s semen (Group 3 data not included in this
review)
Sperm preparation: density gradient centrifugation method
IUI procedure: 0.3 to 0.5 mL
Tomcat catheter for IUI and intrauterine injectors (ZUOI-2) for FSP
Maximum number of cycles per couple: 3
Outcomes Clinical pregnancy per couple
Miscarriage
Multiple pregnancy
Notes Luteal support with 1500 IU hCG on day 5 and day 10 after hCG
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation list
Allocation concealment (selection bias) Unclear risk No details reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No blinding reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcomes reported for all randomised
women (n = 90)
Selective reporting (reporting bias) Unclear risk Live birth not reported
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Ng 2003 (Continued)
Other bias Unclear risk Total motile sperm count in first insemi-
nation significantly different between IUI
group and FSP group
Noci 2007
Methods Randomisation method: randomisation tables
Trial design: three parallel arms-FSP, IUI and intraperitoneal insemination (IPI)-three
cycles
Concealment of allocation: not stated
Power analysis: not stated
Intention-to-treat analysis: not performed
Participants Participants: 71 couples; 101 cycles
(1) IUI 23 women, 34 cycles; (2) FSP 24 women, 33 cycles; and (3) IPI 24 women, 34
cycles (Group 3 data not included in this review)
Age of women: (1) IUI 33.7 ± 1.6 2 years; (2) FSP 35.3 ± 3 years; and (3) IPI 35.3 ± 4.
4 years
Duration of subfertility: (1) IUI 3.4 ± 1.6 years; (2) FSP 3.3 ± 1.9 years; and (3) IPI 3.
3 ± 1.4 years
Type of subfertility:male (not further defined), unexplained subfertility; and endometrio-
sis, mixed
Interventions Stimulation method: recombinant or urinary FSH, dosage titrated later according to the
ovarian response; 10,000 UI of hCG administered when 1 follicle > 18 mm and 2 others
> 16 mm
Sperm preparation: discontinuous density gradient centrifugation method (PureSperm)
IUI procedure: Frydman catheter 0.3 to 0.5 mL
FSP using a hysterosalpingography (Cervix Adaptor) catheter
IPI: direct 2 mL sperm preparation injected into posterior vaginal fornix by a 19-gauge
2.2-cm needle
Maximum number of cycles per couple: 3
Outcomes Clinical pregnancy
Multiple pregnancy
Notes All pregnancies occurred on first cycle
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Couples were randomized by predefined
tables of randomization”
Allocation concealment (selection bias) Unclear risk No details reported
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Noci 2007 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No blinding reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcomes reported for all randomised par-
ticipants (n = 71)
Selective reporting (reporting bias) Unclear risk Live birth not reported. Miscarriage not re-
ported
Other bias Low risk No other potential source of bias noted
Nuojua-Huttunen 1997
Methods Randomisation: computer-generated random numbers
Trial design: parallel
Concealment of allocation: not stated
Power analysis: yes
Participants Participants: 100 women; 100 cycles
Age of women: IUI 31.1 ± 4.0 years; FSP 30.2 ± 4.4 years
Duration of subfertility: IUI 3.8 ± 2.2 years; FSP 2.9 ± 1.7 years
Type of subfertility: male subfertility, unexplained subfertility, mild endometriosis, ovar-
ian dysfunction
Duration of unexplained infertility not reported
Male subfertility defined as sperm quality before treatment normal or slightly abnormal
(> 10 × 106 sperm per mL, > 40% progressive motility [grade A + B], > 30% normal
forms and after a Percoll preparation > 1 × 106 progressively motile sperm per mL)
Interventions Stimulation method: CC + hMG + hCG
Intervention: FSP or IUI 36 hours after hCG, type of semen not stated
Semen preparation: Percoll gradient
Catheter used: Kremer de la Fontaine for IUI; Foley catheter for FSP
Maximum number of cycles per couple: 1





Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random numbers
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Nuojua-Huttunen 1997 (Continued)
Allocation concealment (selection bias) Unclear risk No details reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No blinding reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcomes reported for all randomised par-
ticipants (n = 100)
Selective reporting (reporting bias) Unclear risk Live birth not reported
Other bias Low risk No other potential source of bias noted
Papier 1998
Methods Randomisation: computer-generated random numbers
Trial design: parallel
Concealment of allocation: adequate
Power analysis: no
Participants Participants: 100 women; 87 cycles
Age of women: not stated
Duration of subfertility: at least one year
Type of subfertility: mild male subfertility, unexplained subfertility
Interventions Stimulation method: hMG from CD 5 + hCG
Intervention: FSP 34 hours after hCG and IUI 38 hours after hCG; type of semen not
stated
Semen preparation: Percoll gradient
Catheter used: Frydman for IUI; Makler cannula for FSP
Maximum number of cycles per couple: 1
Outcomes Pregnancy
Notes Luteal support with 400 mg progesterone. Additional details received from authors
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random numbers
Allocation concealment (selection bias) Low risk Adequate
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Papier 1998 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No blinding reported
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 16 participants did not undergo interven-
tion (reasons given), but intention to treat
analysis possible (assuming no pregnancy
in those 16 women)
Selective reporting (reporting bias) Unclear risk Not stated
Other bias Low risk No other potential source of bias noted
Ricci 2001
Methods Randomisation: random number generator on computer
Trial design: parallel
Concealment of allocation: not stated
Power analysis: yes
Participants Participants: 65 women; 132 cycles
Age of women: IUI 34.8 ± 4.6 years; FSP 35.5 ± 3.5 years
Duration of subfertility: IUI 3.5 ± 1.4 years; FSP 3.4 ± 1.3 years
Type of subfertility: unexplained infertility for 2 years
Interventions Stimulation method: u-hFSH + hCG
Intervention: IUI and FSP 36 hours after hCG with husband’s semen
Semen preparation: swim-up
Catheter used: Frydman catheter for IUI; FAST system for FSP




Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number generator on computer
Allocation concealment (selection bias) Unclear risk No details reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No blinding reported
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Ricci 2001 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk No losses to follow-up
Selective reporting (reporting bias) Unclear risk Not stated
Other bias Low risk No other potential source of bias noted
Trout 1999
Methods Randomisation: random number generator
Trial design: parallel
Concealment of allocation: third party
Power analysis: yes
Participants Participants: 268 women; 268 cycles
Age of women: IUI 33.0 ± 2.7 years; FSP 33.0 ± 2.5 years
Duration of subfertility: not stated
Type of subfertility: ovulation dysfunction, unexplained infertility, male factor, en-
dometriosis, cervical mucus factor, multiple diagnosis
Interventions Stimulation method: CC + gonadotropins or gonadotropins alone + hCG
Intervention: IUI or FSP 36 hours after hCG with husband’s semen
Semen preparation: Percoll gradient
Catheter used: IUI catheter for IUI; ZUI II catheter for FSP
Maximum number of cycles per couple: not stated
Outcomes Clinical pregnancy
Ectopic pregnancy
Notes Duration of infertility unknown
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number generator
Allocation concealment (selection bias) Low risk States, “Neither the physicians enrolling
the patients nor the physicians performing
the inseminations had access to the ran-
domization schedule”
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No blinding reported
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Trout 1999 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Data reported for all women who received
interventions, but does not clearly state
how many women randomised, so unclear
whether any dropped out
Selective reporting (reporting bias) Unclear risk Does not report live birth, miscarriage or
OHSS
Other bias Low risk No other potential source of bias noted
CC = clomiphene citrate.
FSH = follicle-stimulating hormone.
FSP = fallopian sperm perfusion.
GnRH = gonadotrophin-releasing hormone.
hMG = human menopausal gonadotropin.
IUI = intrauterine insemination.
LBR = live birth rate.
OHSS = ovarian hyperstimulation syndrome.
PR = pregnancy rate.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Allahbadia 1998 Randomisation method was not stated, and the groups were not equal (369 in IUI group and 20 in FSP
group), which makes adequate randomisation impossible. The author did not reply to our request for further
information. Duration of subfertility was not stated
Arroyo Vieyra 1995 Randomisation method was not stated, and the groups were not equal (95 cycles with IUI and 36 cycles with
FSP), which makes adequate randomisation improbable. The author did not reply to our request for further
information
Ciftci 1998 The trial was quasi-randomised. The duration of subfertility was not stated. The author gave additional
information regarding data after the first cycle. However, these data consisted of only pregnancies per cycle.
Moreover, no data were available on the duration of subfertility
Desai 1998 Randomisation method was not stated, but the groups were not equal (369 in IUI group and 20 in FSP
group), which makes adequate randomisation improbable. The author did not reply to our request for further
information. The duration of subfertility was not stated
Dodson 1998 The trial did not perform the comparison of interest
Elhelw 2000 Letter
Publication did not perform the comparison of interest
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(Continued)
Fanchin 1996 Letter
Publication did not perform the comparison of interest
Fanchin 1997 Letter
Publication did not perform the comparison of interest
Kahn 1992 Cohort study
Kahn 1992a Cohort study
Kahn 1993a This study did not perform the comparison of interest
Karande 1995 Both IUI and FSP were performed on two consecutive days after hCG administration. A substantial number
of women with tubal subfertility were included. The duration of subfertility was not stated
Levitas 1999 This study did not perform the comparison of interest
Li 1993 Case report that described a simple non-invasive method of fallopian tube sperm perfusion. This study did
not perform the comparison of interest
Maheshwari 1998 The trial was quasi-randomised
Mamas 1996 The trial was quasi-randomised
Mamas 2006 The trial did not perform the comparison of interest. Intrauterine tuboperitoneal insemination is not the same
as fallopian tube sperm perfusion
Posada 2005 The trial did not perform the comparison of interest
Prietl 1999 This study compared conventional IUI with intra-tubal insemination, which is different from perfusion of the
fallopian tubes (FSP)
Shekhawat 2012 The method of allocation was not random and used odd and even numbers of the ART register to assign FSP
and IUI. Confirmed in writing by author
Soliman 1999 The trial was a non-controlled randomised trial
Soliman 2005 The trial did not perform the comparison of interest
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Characteristics of studies awaiting assessment [ordered by study ID]
Ricci 2008
Methods RCT
Participants 400 couples with unexplained or mild male factor infertility
Interventions IUI versus FSP in natural cycles
Outcomes Clinical pregnancy, ectopic pregnancy, miscarriage
Notes Study completed December 2009. Emailed lead investigator March 2013-no response to date
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D A T A A N D A N A L Y S E S
Comparison 1. IUI versus FSP




participants Statistical method Effect size
1 Live birth per couple 3 633 Odds Ratio (M-H, Fixed, 95% CI) 0.94 [0.59, 1.49]
2 Clinical pregnancy per couple 14 Odds Ratio (M-H, Random, 95% CI) Subtotals only
3 Multiple pregnancy 8 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
3.1 Multiple pregnancy per
couple




8 197 Odds Ratio (M-H, Fixed, 95% CI) 0.96 [0.44, 2.07]
4 Miscarriage rate 7 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
4.1 Miscarriage per couple 7 884 Odds Ratio (M-H, Fixed, 95% CI) 1.07 [0.56, 2.05]
4.2 Miscarriage per pregnancy 7 180 Odds Ratio (M-H, Fixed, 95% CI) 1.32 [0.63, 2.78]
5 Ectopic pregnancy 4 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
5.1 Ectopic pregnancy per
couple
4 643 Odds Ratio (M-H, Fixed, 95% CI) 0.88 [0.24, 3.19]
5.2 Ectopic pregnancy per
pregnancy
4 111 Odds Ratio (M-H, Fixed, 95% CI) 1.71 [0.42, 6.88]
Comparison 2. IUI versus FSP subgroups by indication




participants Statistical method Effect size
1 Unexplained subfertility 7 378 Odds Ratio (M-H, Fixed, 95% CI) 0.63 [0.39, 1.02]
1.1 Clinical pregnancy 7 378 Odds Ratio (M-H, Fixed, 95% CI) 0.63 [0.39, 1.02]
2 Mild to moderate male factor
subfertility
5 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
2.1 Live birth 1 120 Odds Ratio (M-H, Fixed, 95% CI) 0.40 [0.14, 1.14]
2.2 Clinical pregnancy 5 303 Odds Ratio (M-H, Fixed, 95% CI) 0.53 [0.28, 1.01]
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Analysis 1.1. Comparison 1 IUI versus FSP, Outcome 1 Live birth per couple.
Review: Intrauterine insemination versus fallopian tube sperm perfusion for non-tubal infertility
Comparison: 1 IUI versus FSP
Outcome: 1 Live birth per couple
Study or subgroup IUI FSP Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
El Sadek 1998 7/48 8/48 18.5 % 0.85 [ 0.28, 2.57 ]
El-Khayat 2012 6/60 13/60 31.7 % 0.40 [ 0.14, 1.14 ]
Farquhar 2013 27/210 21/207 49.9 % 1.31 [ 0.71, 2.39 ]
Total (95% CI) 318 315 100.0 % 0.94 [ 0.59, 1.49 ]
Total events: 40 (IUI), 42 (FSP)
Heterogeneity: Chi2 = 3.72, df = 2 (P = 0.16); I2 =46%
Test for overall effect: Z = 0.28 (P = 0.78)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours FSP Favours IUI
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Analysis 1.2. Comparison 1 IUI versus FSP, Outcome 2 Clinical pregnancy per couple.
Review: Intrauterine insemination versus fallopian tube sperm perfusion for non-tubal infertility
Comparison: 1 IUI versus FSP
Outcome: 2 Clinical pregnancy per couple








Biacchiardi 2004 (1) 8/34 1/22 6.46 [ 0.75, 55.86 ]
El Sadek 1998 8/48 9/48 0.87 [ 0.30, 2.48 ]
El-Khayat 2012 7/60 16/60 0.36 [ 0.14, 0.96 ]
Farquhar 2013 30/211 24/206 1.26 [ 0.71, 2.23 ]
Furuya 2010 (2) 6/80 9/78 0.62 [ 0.21, 1.84 ]
Gregoriou 1995 12/30 11/30 1.15 [ 0.41, 3.26 ]
Kahn 1993 5/28 14/30 0.25 [ 0.07, 0.83 ]
Kamel 1999 6/60 8/60 0.72 [ 0.23, 2.22 ]
Ng 2003 11/30 17/30 0.44 [ 0.16, 1.25 ]
Noci 2007 2/34 7/33 0.23 [ 0.04, 1.21 ]
Nuojua-Huttunen 1997 10/50 4/50 2.88 [ 0.84, 9.88 ]
Papier 1998 9/50 5/50 1.98 [ 0.61, 6.38 ]
Ricci 2001 6/32 16/33 0.25 [ 0.08, 0.75 ]
Trout 1999 14/137 18/131 0.71 [ 0.34, 1.50 ]
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours FSP Favours IUI
(1) Pre cross-over data
(2) 1st cycle only
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Analysis 1.3. Comparison 1 IUI versus FSP, Outcome 3 Multiple pregnancy.
Review: Intrauterine insemination versus fallopian tube sperm perfusion for non-tubal infertility
Comparison: 1 IUI versus FSP
Outcome: 3 Multiple pregnancy
Study or subgroup IUI FSP Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Multiple pregnancy per couple
El Sadek 1998 1/48 2/48 11.6 % 0.49 [ 0.04, 5.58 ]
El-Khayat 2012 1/60 1/60 5.8 % 1.00 [ 0.06, 16.37 ]
Farquhar 2013 4/211 2/206 11.7 % 1.97 [ 0.36, 10.88 ]
Ng 2003 2/30 5/30 27.6 % 0.36 [ 0.06, 2.01 ]
Noci 2007 1/34 3/33 17.5 % 0.30 [ 0.03, 3.07 ]
Nuojua-Huttunen 1997 1/50 0/50 2.9 % 3.06 [ 0.12, 76.95 ]
Ricci 2001 1/32 3/16 22.9 % 0.14 [ 0.01, 1.47 ]
Subtotal (95% CI) 465 443 100.0 % 0.62 [ 0.29, 1.32 ]
Total events: 11 (IUI), 16 (FSP)
Heterogeneity: Chi2 = 5.15, df = 6 (P = 0.52); I2 =0.0%
Test for overall effect: Z = 1.24 (P = 0.22)
2 Sensitivity analysis: multiple pregnancy per pregnancy
El Sadek 1998 1/8 2/9 12.5 % 0.50 [ 0.04, 6.86 ]
El-Khayat 2012 1/7 1/16 4.0 % 2.50 [ 0.13, 46.77 ]
Fanchin 1995 3/10 7/20 24.7 % 0.80 [ 0.16, 4.08 ]
Farquhar 2013 4/30 2/24 14.6 % 1.69 [ 0.28, 10.13 ]
Ng 2003 2/11 5/17 24.4 % 0.53 [ 0.08, 3.40 ]
Noci 2007 1/2 3/7 5.1 % 1.33 [ 0.06, 31.12 ]
Nuojua-Huttunen 1997 1/10 0/4 4.5 % 1.42 [ 0.05, 42.22 ]
Ricci 2001 1/6 3/16 10.3 % 0.87 [ 0.07, 10.42 ]
Subtotal (95% CI) 84 113 100.0 % 0.96 [ 0.44, 2.07 ]
Total events: 14 (IUI), 23 (FSP)
Heterogeneity: Chi2 = 1.57, df = 7 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 0.11 (P = 0.91)
Test for subgroup differences: Chi2 = 0.62, df = 1 (P = 0.43), I2 =0.0%
0.02 0.1 1 10 50
Favours IUI Favours FSP
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Analysis 1.4. Comparison 1 IUI versus FSP, Outcome 4 Miscarriage rate.
Review: Intrauterine insemination versus fallopian tube sperm perfusion for non-tubal infertility
Comparison: 1 IUI versus FSP
Outcome: 4 Miscarriage rate
Study or subgroup IUI FSP Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Miscarriage per couple
El Sadek 1998 1/48 1/48 5.6 % 1.00 [ 0.06, 16.46 ]
El-Khayat 2012 1/60 2/60 11.3 % 0.49 [ 0.04, 5.57 ]
Farquhar 2013 9/211 9/206 50.1 % 0.98 [ 0.38, 2.51 ]
Kahn 1993 1/28 2/30 10.7 % 0.52 [ 0.04, 6.06 ]
Ng 2003 4/11 2/17 5.7 % 4.29 [ 0.63, 29.23 ]
Nuojua-Huttunen 1997 2/50 2/50 11.0 % 1.00 [ 0.14, 7.39 ]
Ricci 2001 1/32 1/33 5.5 % 1.03 [ 0.06, 17.24 ]
Subtotal (95% CI) 440 444 100.0 % 1.07 [ 0.56, 2.05 ]
Total events: 19 (IUI), 19 (FSP)
Heterogeneity: Chi2 = 2.78, df = 6 (P = 0.84); I2 =0.0%
Test for overall effect: Z = 0.20 (P = 0.84)
2 Miscarriage per pregnancy
El Sadek 1998 1/8 1/9 6.9 % 1.14 [ 0.06, 21.87 ]
El-Khayat 2012 1/7 2/16 8.7 % 1.17 [ 0.09, 15.46 ]
Farquhar 2013 9/26 9/21 54.5 % 0.71 [ 0.22, 2.30 ]
Kahn 1993 1/5 2/14 7.0 % 1.50 [ 0.11, 21.31 ]
Ng 2003 4/11 2/17 8.4 % 4.29 [ 0.63, 29.23 ]
Nuojua-Huttunen 1997 2/10 2/16 10.3 % 1.75 [ 0.21, 14.93 ]
Ricci 2001 1/6 1/14 4.2 % 2.60 [ 0.14, 50.05 ]
Subtotal (95% CI) 73 107 100.0 % 1.32 [ 0.63, 2.78 ]
Total events: 19 (IUI), 19 (FSP)
Heterogeneity: Chi2 = 2.82, df = 6 (P = 0.83); I2 =0.0%
Test for overall effect: Z = 0.73 (P = 0.47)
Test for subgroup differences: Chi2 = 0.17, df = 1 (P = 0.68), I2 =0.0%
0.02 0.1 1 10 50
Increased by IUI Increased by FSP
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Analysis 1.5. Comparison 1 IUI versus FSP, Outcome 5 Ectopic pregnancy.
Review: Intrauterine insemination versus fallopian tube sperm perfusion for non-tubal infertility
Comparison: 1 IUI versus FSP
Outcome: 5 Ectopic pregnancy
Study or subgroup IUI FSP Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Ectopic pregnancy per couple
El-Khayat 2012 0/60 1/60 30.4 % 0.33 [ 0.01, 8.21 ]
Farquhar 2013 2/211 1/206 20.5 % 1.96 [ 0.18, 21.80 ]
Kahn 1993 1/28 0/30 9.4 % 3.33 [ 0.13, 85.11 ]
Ricci 2001 0/32 1/16 39.8 % 0.16 [ 0.01, 4.13 ]
Subtotal (95% CI) 331 312 100.0 % 0.88 [ 0.24, 3.19 ]
Total events: 3 (IUI), 3 (FSP)
Heterogeneity: Chi2 = 2.49, df = 3 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 0.20 (P = 0.84)
2 Ectopic pregnancy per pregnancy
El-Khayat 2012 0/7 1/16 30.5 % 0.69 [ 0.02, 19.00 ]
Farquhar 2013 2/26 1/21 34.6 % 1.67 [ 0.14, 19.76 ]
Kahn 1993 1/5 0/14 7.3 % 9.67 [ 0.33, 281.33 ]
Ricci 2001 0/6 1/16 27.6 % 0.79 [ 0.03, 22.19 ]
Subtotal (95% CI) 44 67 100.0 % 1.71 [ 0.42, 6.88 ]
Total events: 3 (IUI), 3 (FSP)
Heterogeneity: Chi2 = 1.51, df = 3 (P = 0.68); I2 =0.0%
Test for overall effect: Z = 0.75 (P = 0.45)
Test for subgroup differences: Chi2 = 0.48, df = 1 (P = 0.49), I2 =0.0%
0.005 0.1 1 10 200
Favours IUI Favours FSP
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Analysis 2.1. Comparison 2 IUI versus FSP subgroups by indication, Outcome 1 Unexplained subfertility.
Review: Intrauterine insemination versus fallopian tube sperm perfusion for non-tubal infertility
Comparison: 2 IUI versus FSP subgroups by indication
Outcome: 1 Unexplained subfertility
Study or subgroup IUI FSP Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Clinical pregnancy
Biacchiardi 2004 (1) 8/34 1/22 2.2 % 6.46 [ 0.75, 55.86 ]
Gregoriou 1995 12/30 11/30 15.7 % 1.15 [ 0.41, 3.26 ]
Kahn 1993 5/28 14/30 26.4 % 0.25 [ 0.07, 0.83 ]
Noci 2007 1/16 6/19 12.2 % 0.14 [ 0.02, 1.36 ]
Nuojua-Huttunen 1997 6/26 2/26 3.7 % 3.60 [ 0.65, 19.84 ]
Ricci 2001 6/32 16/33 30.4 % 0.25 [ 0.08, 0.75 ]
Trout 1999 1/27 4/25 9.5 % 0.20 [ 0.02, 1.95 ]
Total (95% CI) 193 185 100.0 % 0.63 [ 0.39, 1.02 ]
Total events: 39 (IUI), 54 (FSP)
Heterogeneity: Chi2 = 17.42, df = 6 (P = 0.01); I2 =66%
Test for overall effect: Z = 1.88 (P = 0.060)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours FSP Favours IUI
(1) Pre cross-over data
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Analysis 2.2. Comparison 2 IUI versus FSP subgroups by indication, Outcome 2 Mild to moderate male
factor subfertility.
Review: Intrauterine insemination versus fallopian tube sperm perfusion for non-tubal infertility
Comparison: 2 IUI versus FSP subgroups by indication
Outcome: 2 Mild to moderate male factor subfertility
Study or subgroup IUI FSP Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Live birth
El-Khayat 2012 6/60 13/60 100.0 % 0.40 [ 0.14, 1.14 ]
Subtotal (95% CI) 60 60 100.0 % 0.40 [ 0.14, 1.14 ]
Total events: 6 (IUI), 13 (FSP)
Heterogeneity: not applicable
Test for overall effect: Z = 1.71 (P = 0.087)
2 Clinical pregnancy
El-Khayat 2012 7/60 16/60 54.9 % 0.36 [ 0.14, 0.96 ]
Kamel 1999 6/60 8/60 28.0 % 0.72 [ 0.23, 2.22 ]
Noci 2007 1/6 1/3 4.3 % 0.40 [ 0.02, 10.02 ]
Nuojua-Huttunen 1997 2/6 1/3 3.5 % 1.00 [ 0.05, 18.91 ]
Trout 1999 2/20 3/25 9.3 % 0.81 [ 0.12, 5.42 ]
Subtotal (95% CI) 152 151 100.0 % 0.53 [ 0.28, 1.01 ]
Total events: 18 (IUI), 29 (FSP)
Heterogeneity: Chi2 = 1.28, df = 4 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 1.93 (P = 0.054)
Test for subgroup differences: Chi2 = 0.19, df = 1 (P = 0.66), I2 =0.0%
0.01 0.1 1 10 100
Favours FSP Favours IUI
A D D I T I O N A L T A B L E S
Table 1. Per cycle data
Study Clinical pregnancy per cycle
IUI FSP P value
Fanchin 1995 10/50 (20%) 20/50 (40%) P < 0.04
Filer 1996 12/59 (20%) 5/47 (11%) P > 0.05
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A P P E N D I C E S
Appendix 1. MEDLINE
1 Insemination, Artificial/ (6821)
2 (intrauter$ adj5 inseminat$).tw. (1194)
3 (intra-uter$ adj5 inseminat$).tw. (131)
4 IUI.tw. (703)
5 or/1-4 (7614)
6 fallopian tube sperm perfusion.tw. (19)
7 FSP.tw. (446)
8 (Fallopian adj5 sperm$).tw. (97)
9 (tub$ adj5 sperm$).tw. (1868)
10 sperm$ flush$.tw. (7)
11 or/6-10 (2326)
12 5 and 11 (80)
13 randomised controlled trial.pt. (234274)
14 controlled clinical trial.pt. (74820)
15 Randomized Controlled Trials/ (48327)
16 Random allocation/ (57750)
17 Double-blind method/ (91028)
18 Single-blind method/ (10880)
19 or/13-18 (397294)
20 clinical trial.pt. (435392)
21 exp clinical trials/ (190560)
22 (clin$ adj25 trial$).ti,ab,sh. (129372)




27 Research design/ (47276)
28 or/20-27 (866440)
29 animal/ not (human/ and animal/) (3095759)
30 19 or 28 (873731)
31 30 not 29 (800552)
32 12 and 31 (23)
33 (2003$ or 2004$ or 2005$ or 2006$ or 2007$).ed. (3111083)
34 32 and 33 (5)
35 from 34 keep 1-5 (5)
Appendix 2. CENTRAL
1 Insemination, Artificial/ (112)
2 (intrauter$ adj5 inseminat$).tw. (290)
3 (intra-uter$ adj5 inseminat$).tw. (22)
4 IUI.tw. (206)
5 or/1-4 (378)
6 fallopian tube sperm perfusion.tw. (21)
7 FSP.tw. (30)
8 (Fallopian adj5 sperm$).tw. (29)
9 (tub$ adj5 sperm$).tw. (47)
10 sperm$ flush$.tw. (0)
11 or/6-10 (70)
12 5 and 11 (30)
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13 from 12 keep 1-30 (30)
Appendix 3. CINAHL
1 Insemination, Artificial/ (163)
2 (intrauter$ adj5 inseminat$).tw. (30)
3 (intra-uter$ adj5 inseminat$).tw. (4)
4 IUI.tw. (16)
5 or/1-4 (178)
6 fallopian tube sperm perfusion.tw. (2)
7 FSP.tw. (17)
8 (Fallopian adj5 sperm$).tw. (2)
9 (tub$ adj5 sperm$).tw. (7)
10 sperm$ flush$.tw. (0)
11 or/6-10 (22)
12 5 and 11 (2)
13 exp clinical trials/ (43714)
14 Clinical trial.pt. (20712)
15 (clinic$ adj trial$1).tw. (10227)
16 ((singl$ or doubl$ or trebl$ or tripl$) adj (blind$3 or mask$3)).tw. (6114)
17 Randomi?ed control$ trial$.tw. (8946)
18 Random assignment/ (15159)
19 Random$ allocat$.tw. (1023)
20 Placebo$.tw. (8559)
21 Placebos/ (3489)
22 Quantitative studies/ (3196)
23 Allocat$ random$.tw. (60)
24 or/13-23 (61301)
25 12 and 24 (2)
26 from 25 keep 1-2 (2)
Appendix 4. EMBASE
1 fallopian tube sperm perfusion.tw. (22)
2 FSP.tw. (345)
3 (Fallopian adj5 sperm$).tw. (80)
4 (tub$ adj5 sperm$).tw. (1383)
5 sperm$ flush$.tw. (5)
6 or/1-5 (1737)
7 exp Artificial Insemination/ (3671)
8 (intrauter$ adj5 inseminat$).tw. (1172)
9 (intra-uter$ adj5 inseminat$).tw. (129)
10 IUI.tw. (737)
11 or/7-10 (4753)
12 6 and 11 (74)
13 Controlled study/ or randomised controlled trial/ (2405316)
14 double blind procedure/ (63789)
15 single blind procedure/ (6559)
16 crossover procedure/ (18585)
17 drug comparison/ (81250)
18 placebo/ (97915)
19 random$.ti,ab,hw,tn,mf. (367123)
20 latin square.ti,ab,hw,tn,mf. (1064)
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24 ((doubl$ or singl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).ti,ab,hw,tn,mf. (106285)
25 (comparative adj5 trial$).ti,ab,hw,tn,mf. (5769)
26 (clinical adj5 trial$).ti,ab,hw,tn,mf. (483066)
27 or/13-26 (2886258)
28 nonhuman/ (2878264)
29 animal/ not (human/ and animal/) (12847)
30 or/28-29 (2881866)
31 27 not 30 (1695407)
32 12 and 31 (28)
33 (2003$ or 2004$ or 2005$ or 2006$ or 2007$).em. (2449289)
34 32 and 33 (6)
35 from 34 keep 1-6 (6)
Appendix 5. Data collected
Types of participant
• What was the duration of subfertility?
• Were prognostic factors such as the age of the woman and the duration of subfertility considered?
• Were female factors excluded or corrected? All women had to have regular menstrual cycles with biphasic body temperature
charts or normal luteal progesterone; patent tubes on hysterosalpingography (HSG) or laparoscopy; no cervical factors, thus a positive
post-coital test or normal cervical mucus with pH > 6.3 and Insler score > 11.
• Had treatments been applied previously? Was it tubal surgery, controlled ovarian hyperstimulation without insemination, or
other?
Types of intervention
• What method of controlled ovarian hyperstimulation (COH) was used?
• Were criteria to cancel the insemination because of the risk of multiple pregnancies or ovarian hyperstimulation syndrome
(cancellation criteria) described?
• Duration of treatment: How many treatment cycles were offered?
• How many inseminations were performed per cycle?
• What timing method was used in natural cycles: with luteinising hormone (LH) in blood or urine?
• What timing method was used in cycles with COH. When no GnRHa was used: Was LH also measured in cycles with COH?
• What was the actual timing of IUI or FSP? Was IUI or FSP in natural cycles performed 20 to 40 hours after the onset of the LH
surge was detected, and in cycles with COH 35 to 45 hours after hCG?
• Which semen was inseminated (donor semen or partner semen)?
• What method of semen preparation was applied?
• What were the semen characteristics before and after sperm processing (especially the number of motile spermatozoa that were
inseminated)?
Types of outcome measure
· Primary outcome
• Number of live births
· Secondary outcomes
• Number of clinical pregnancies
• Number of multiple pregnancies
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• Spontaneous abortion rate
• Number of tubal pregnancies
WH A T ’ S N E W
Last assessed as up-to-date: 12 September 2013.
Date Event Description
12 September 2013 New search has been performed New search, September 2013. Added five RCTs:
El-Khayat 2012; Farquhar 2013; Furuya 2010 (new
RCTs); Noci 2007; Kamel 1999 (previously classified
as awaiting assessment). Added one RCT to awaiting
assessment section: Ricci 2008.
12 September 2013 New citation required but conclusions have not
changed
There has been no change to the conclusions of this
review
H I S T O R Y
Protocol first published: Issue 2, 1999
Review first published: Issue 3, 2004
Date Event Description
11 February 2009 New citation required but conclusions have not
changed
Review updated Dec 2007
1 October 2008 New search has been performed Search revised and re-run; new study added (Ng et al
2003) and two studies waiting for assessment
3 June 2008 Amended Converted to new review format.
6 December 2007 New citation required and conclusions have changed Substantive amendment
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